Gonul Velicelebi

This inventor holds 29 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Calcium Modulation. Top assignees: Calcimedica, Inc., Sibia Neurosciences, Inc., Merck + Co., Inc.. Active years: 1987-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gonul Velicelebi. Retrieved from https://idiyas.com/inventor/gonul-velicelebi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29 (Patent Applications = 7)

% Patents Active = 65.5

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 4.6

ph-index = 9

Forward Citations = 410(Granted Patents)

Location History:

San Deigo, CA (US) (2013)
San Diego, CA (US) (1987 - 2023)

Company Filing History:

Sibia Neurosciences, Inc.

Science Applications International Corporation

Neurogenetic Pharmaceuticals, Inc.

The Salk Institute Biotechnology Industrial Associates, Inc.

patents

10. 1 out of 834,659

Other

patents

where one patent can have more than one assignee

Years Active: 1987-2023

Loading Chart...

Areas of Expertise:

Pyrazine-Containing Compound

Calcium Channel Proteins

Gamma-Secretase Modulators

Trisubstituted Thiophenes

Signal-Based Assays

Mitochondrial Interactions

Human Neuronal Receptors

Vasoactive Intestinal Peptide

GRF Analogs

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11752148 - Pyrazine-containing compound (2023-09-12),

2. 11439639 - Pyrazine-containing compound (2022-09-13),

3. 11311535 - Pancreatitis treatment (2022-04-26),

4. 11013737 - Pyrazine-containing compound (2021-05-25),

5. 10821109 - Pyrazine-containing compound (2020-11-03),

6. 8871460 - Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor (2014-10-28),

7. 8524765 - Compounds that modulate intracellular calcium (2013-09-03),

8. 8507269 - Calcium channel proteins and uses thereof (2013-08-13),

9. 8394848 - Compounds that modulate intracellular calcium (2013-03-12),

10. 8389567 - Compounds that modulate intracellular calcium (2013-03-05),

11. 8383670 - Trisubstituted thiophenes that modulate intracellular calcium (2013-02-26),

12. 8372991 - Trisubstituted thiophenes that modulate intracellular calcium (2013-02-12),

13. 8323648 - Methods of modulating and identifying agents that modulate intracellular calcium (2012-12-04),

14. 8263641 - Compounds that modulate intracellular calcium (2012-09-11),

15. 7981925 - Compounds that modulate intracellular calcium (2011-07-19),

Title: The Innovative Journey of Inventor Gonul Velicelebi

Introduction: Gonul Velicelebi is a pioneering inventor based in San Diego, CA, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Velicelebi holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing her commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Velicelebi has worked with leading tech companies and research institutions to develop cutting-edge solutions that have revolutionized various industries. Her innovative mindset and passion for creating impactful change have earned her recognition as a trailblazer in the field.

Collaborations: Throughout her career, Velicelebi has collaborated with top engineers, scientists, and researchers to bring her ideas to life. Her ability to work effectively in multidisciplinary teams has led to the successful implementation of numerous projects that have had a lasting impact on the tech landscape.

Conclusion: Gonul Velicelebi's dedication to innovation and her relentless pursuit of excellence have solidified her position as a prominent figure in the world of technology. Her inventive spirit continues to inspire the next generation of inventors and serves as a testament to the power of creativity and perseverance in driving meaningful change.

Profile summary based on public USPTO records.